Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Paid-in capital	Noncontrolling interest	Retained earnings	Treasury stock	AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Stockholders' Equity Attributable to Noncontrolling Interest					$ 12,368
Total stockholders’ equity	$ 1,071,178
Beginning Balance at Feb. 01, 2020			$ 1,033	$ 404,983		$ 2,313,745	$ (1,552,065)	$ (108,886)
Beginning balance, shares outstanding at Feb. 01, 2020			62,786				40,514
Net income attributable to noncontrolling interests	5,067
Net income (loss) attributable to A&F						(114,021)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(108,954)
Purchase of common stock	(15,172)
Purchase of common stock, shares			1,397				1,397
Dividends	(12,556)					(12,556)
Share-based compensation issuances and exercises	(5,694)	[1]		(22,382)		(37,698)	$ (54,386)
Share-based compensation issuances and exercises, shares			(1,010)				(1,010)
Share-based compensation expense	18,682			18,682
Derivative financial instruments, net of tax	(5,616)							(5,616)
Foreign currency translation adjustments, net of tax	12,195							12,195
Distributions to noncontrolling interests, net	$ (4,751)				(4,751)
Ending Balance at Jan. 30, 2021			$ 1,033	401,283		2,149,470	$ (1,512,851)	(102,307)
Ending balance, shares outstanding at Jan. 30, 2021			62,399				40,901
Common stock, dividends declared (in dollars per share)	$ 0.28
Stockholders' Equity Attributable to Noncontrolling Interest					12,684
Total stockholders’ equity	$ 949,312
Net income attributable to noncontrolling interests	7,056
Net income (loss) attributable to A&F						263,010
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	270,066
Purchase of common stock	$ (377,290)
Purchase of common stock, shares	377,290		10,200				10,200
Share-based compensation issuances and exercises	$ (13,163)	[1]		(17,397)		(26,324)	$ (30,558)
Share-based compensation issuances and exercises, shares			(786)				(786)
Share-based compensation expense	29,304			29,304
Derivative financial instruments, net of tax	10,518							10,518
Foreign currency translation adjustments, net of tax	(22,917)							(22,917)
Distributions to noncontrolling interests, net	(8,506)				(8,506)
Ending Balance at Jan. 29, 2022	826,090		$ 1,033	413,190		2,386,156	$ (1,859,583)	(114,706)
Ending balance, shares outstanding at Jan. 29, 2022			52,985				50,315
Stockholders' Equity Attributable to Noncontrolling Interest	11,234				11,234
Total stockholders’ equity	837,324
Net income attributable to noncontrolling interests	7,569
Net income (loss) attributable to A&F						2,816
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	10,385
Purchase of common stock	(125,775)
Purchase of common stock, shares			4,770				4,770
Share-based compensation issuances and exercises	(14,464)	[1]		(25,930)		(20,157)	$ (31,623)
Share-based compensation issuances and exercises, shares			(787)				(787)
Share-based compensation expense	28,995
Derivative financial instruments, net of tax	(10,857)
Foreign currency translation adjustments, net of tax	(11,964)
Distributions to noncontrolling interests, net	(7,075)				(7,075)
Ending Balance at Jan. 28, 2023	694,841		$ 1,033	$ 416,255		$ 2,368,815	$ (1,953,735)	$ (137,527)
Ending balance, shares outstanding at Jan. 28, 2023			49,002				54,298
Stockholders' Equity Attributable to Noncontrolling Interest	11,728				$ 11,728
Total stockholders’ equity	$ 706,569

[1] (1)    Classified within other financing activities on the Consolidated Statements of Cash Flows.